BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.62
+0.14 (1.65%)
At close: Mar 9, 2026, 4:00 PM EDT
8.59
-0.03 (-0.35%)
After-hours: Mar 9, 2026, 7:17 PM EDT
BioCryst Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,162 | 1,642 | 1,558 | 1,227 | 2,140 | 2,492 | |
| Market Cap Growth | 11.15% | 5.43% | 26.97% | -42.68% | -14.12% | 89.45% | |
| Enterprise Value | 2,364 | 2,112 | 2,070 | 1,675 | 2,435 | 2,603 | |
| Last Close Price | 8.62 | 7.80 | 7.52 | 5.99 | 11.48 | 13.85 | |
| PE Ratio | 7.12 | 6.22 | - | - | - | - | |
| Forward PE | 36.42 | 33.02 | - | - | - | - | |
| PS Ratio | 2.47 | 1.88 | 3.46 | 3.70 | 7.90 | 15.86 | |
| PB Ratio | - | -13.78 | -3.27 | -2.69 | -7.26 | -23.29 | |
| P/FCF Ratio | 6.27 | 4.76 | - | - | - | - | |
| P/OCF Ratio | 6.22 | 4.73 | - | - | - | - | |
| EV/Sales Ratio | 2.70 | 2.42 | 4.59 | 5.05 | 8.99 | 16.56 | |
| EV/EBITDA Ratio | 6.74 | 6.02 | 1194.32 | - | - | - | |
| EV/EBIT Ratio | 6.81 | 6.08 | - | - | - | - | |
| EV/FCF Ratio | 6.86 | 6.13 | - | - | - | - | |
| Debt / Equity Ratio | -4.01 | -4.01 | -1.77 | -1.86 | -2.52 | -5.54 | |
| Debt / EBITDA Ratio | 1.35 | 1.35 | 208.58 | - | - | - | |
| Debt / FCF Ratio | 1.38 | 1.38 | - | - | - | - | |
| Net Debt / Equity Ratio | -1.70 | -1.70 | -1.09 | -1.01 | -1.08 | -0.80 | |
| Net Debt / EBITDA Ratio | 0.58 | 0.58 | 300.39 | -4.79 | -2.17 | -0.48 | |
| Net Debt / FCF Ratio | 0.59 | 0.59 | -9.79 | -4.72 | -1.94 | -0.59 | |
| Asset Turnover | 1.74 | 1.74 | 0.90 | 0.62 | 0.48 | 0.34 | |
| Inventory Turnover | 26.83 | 26.83 | 10.10 | 7.70 | 12.00 | 18.93 | |
| Quick Ratio | 1.95 | 1.95 | 2.49 | 2.97 | 4.50 | 5.18 | |
| Current Ratio | 2.06 | 2.06 | 2.63 | 3.31 | 4.89 | 5.46 | |
| Return on Assets (ROA) | 43.21% | 43.21% | -0.16% | -11.57% | -16.30% | -24.07% | |
| Return on Invested Capital (ROIC) | 413.47% | 535.23% | -5.24% | -738.74% | -24821.91% | - | |
| Return on Capital Employed (ROCE) | 109.20% | 109.20% | -0.40% | -26.90% | -33.40% | -36.70% | |
| Earnings Yield | 12.21% | 16.07% | -5.71% | -18.47% | -11.55% | -7.39% | |
| FCF Yield | 15.95% | 21.00% | -3.41% | -7.93% | -7.63% | -5.80% | |
| Buyback Yield / Dilution | -5.75% | -5.75% | -7.54% | -3.38% | -3.79% | -7.08% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.